Centre for Cellular and Molecular Platforms, India’s premier science and technology innovation hub in the life sciences domain has inked a pact to launch a bilateral innovation collaboration in the ...
Mirum Pharmaceuticals, Inc. announced that the US Food and Drug Administration (FDA) has approved Ctexli (chenodiol) tablets, a bile acid, for the treatment of adults with cerebrotendinous ...
The Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in combination with bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment of adult patients with newly ...
Millennium Dental Technologies, Inc., a developer of the LANAP protocol for the treatment of periodontal disease, announced it has been awarded a new US Patent (#12,011,326) for laser-assisted ...
Healthark reveals game-changing trends in India’s life sciences & healthcare GCC sector: Our Bureau, Mumbai Wednesday, ...
YolTech Therapeutics reports positive clinical data for YOLT-203, an in vivo gene editing therapy for primary hyperoxaluria type 1: Shanghai, China Wednesday, February 26, 2025, 1 ...
Nandita Vijayasimha, Bengaluru Wednesday, February 26, 2025, 08:00 Hrs [IST] ...
Two-phase study leads to Monteloeder’s newest nootropic for cognitive performance: Madrid Wednesday, February 26, 2025, 18:00 Hrs [IST] A new study illustrates the research jour ...
Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients: Indianapolis Wednesday, February 26, 2025, 17:00 Hrs [IST] Eli Lilly and Company announ ...
Elanco Animal Health inks agreement with Medgene to commercialize highly pathogenic avian influenza vaccine in dairy cattle: Greenfield, Indiana Wednesday, February 26, 2025, 15:0 ...
EY-Parthenon & Microsoft unveil pharma AI adoption framework at BioAsia 2025: Our Bureau, Mumbai Wednesday, February 26, 2025, 12:10 Hrs [IST] EY-Parthenon and Microsoft have laun ...
Telangana life sciences sector gets a major boost at Bio Asia 2025: Our Bureau, Mumbai Wednesday, February 26, 2025, 11:30 Hrs [IST] The 22nd edition of BioAsia 2025, Asia’s lar ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果